Navigation Links
Cardiome to Present at Bear Stearns Conference
Date:9/6/2007

ptember 2006. A Phase 2b study for vernakalant (oral) is ongoing.

In April 2007 Cardiome acquired exclusive worldwide rights for GED-aPC for all indications. Cardiome intends to initially develop GED-aPC in cardiogenic shock, a life-threatening form of acute circulatory failure due to cardiac dysfunction, which is a leading cause of death for patients hospitalized following a heart attack.

Cardiome is traded on the Toronto Stock Exchange (COM) and the NASDAQ National Market (CRME).

Forward-Looking Statement Disclaimer

Certain statements in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or forward-looking information under applicable Canadian securities legislation that may not be based on historical fact, including without limitation statements containing the words "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect" and similar expressions. Such forward-looking statements or information involve known and unknown risks, uncertainties and other factors that may cause our actual results, events or developments, or industry results, to be materially different from any future results, events or developments expressed or implied by such forward-looking statements or information. Such factors include, among others, our stage of development, lack of product revenues, additional capital requirements, risk associated with the completion of clinical trials and obtaining regulatory approval to market our products, the ability to protect our intellectual property, dependence on collaborative partners and the prospects for negotiating additional corporate collaborations or licensing arrangements and their timing. Specifically, certain risks and uncertainties that could cause such actual events or results expressed or implied by such forward-looking statements and information to differ materially from any future events or results expresse
'/>"/>

SOURCE Cardiome Pharma Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Anti-obesity Drugs Claimed Additional Benefits on cardiometabolic Risk Factors Questioned
2. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
3. Researchers Present Ways To Reduce The Risk Of Dementia
4. Researchers Present Data Regarding The Efficiency Of Herbs
5. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
6. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
7. Drug Reactions First Present Themselves In The Mouth
8. Reminiscing Into The Past Makes You Dissatisfied With The Present
9. Living In The Past Indicates Dissatisfaction With Present
10. Movies Represent Coma In A Wrong Way
11. Onchocerciasis: Presentation And Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Kayentis, the global leader of Digital Pen and Paper technology ... for clinical trials, today announced that it is ranked among ... 500 - EMEA 2009. , ... ... integrated software solutions for the capture, digitalization and management of ...
(Date:12/16/2009)... marketing campaign , ... Englewood, CO ... Genetown™ Hotbed Campaign as its largest yearly promotion for ... MassBio and showcases 37 Massachusetts companies across biotechnology, ... brand on an electronic and printed map that ...
(Date:12/16/2009)... uninsured, government report finds , , WEDNESDAY, Dec. 16 (HealthDay ... year, 45.4 million Americans of all ages -- or ... insurance, according to new National Health Interview Survey statistics ... people of all ages had been uninsured for at ... and 31.9 million (10.6 percent) had been uninsured for ...
(Date:12/16/2009)... -- Shoppers like knowing if their salad is ... grocers have found it burdensome to implement the ... them to provide the information at point of ... for easily making grocery and produce signs ... require retailers of unprocessed fruits, vegetables and other ...
(Date:12/16/2009)... Medical travel facilitator Companion Global Healthcare ... Rico into its network of international hospitals that ... those at mainland U.S. facilities. ,, The announcement ... assistance and preferred pricing for its individual clients ... either HIMA San Pablo Bayamon or HIMA San ...
Breaking Medicine News(10 mins):Health News:With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009 2Health News:Thriving Bioscience Region Leaves Its Mark 2Health News:Over 45 Million Americans Now Lack Health Insurance 2Health News:New Website Helps Grocers Comply With COOL Laws 2Health News:Hospitals in Puerto Rico Join Companion Global Healthcare's Network 2
... associated with any biological or adverse health effects, according ... risks from mobile telephone technology. , The Mobile Telecommunications ... September 12 as part of its 2007 Report. , ... Emeritus Professor of Physics at The University of Nottingham, ...
... Pink Savings Cards Give Tanger Shoppers the Chance to Help ... Saving Money on Their Purchases, GREENSBORO, N.C., Sept. 12 ... at Tanger Outlet Centers. Tanger is celebrating its,14th anniversary in ... Shoppers can join Tanger in its effort to save lives ...
... to the Public, ATLANTA, Sept. 12 ... investment company is about to launch a new ... will bring,professional-grade physical therapy and sports rehabilitation services ... http://www.newscom.com/cgi-bin/prnh/20070912/DCW010LOGO ) AMB Group, LLC, today ...
... Inc., a,pioneer in health and condition (disease) management, ... Synergy Personal Health,Management program at DMAA,s Disease Management ... at Caesar,s Palace in Las,Vegas. With the ... to stay,informed of the best practices, latest technologies ...
... Liberty State Park to celebrate and press for ... JERSEY CITY, N.J., Sept. 12 , What: The joint New Jersey/New York ... centerpiece of more than 50 celebratory and advocacy ... of Americans who are in long-term recovery from addiction to ...
... grant and an Ontario Early Researcher Award, Prof. Yu ... http://amnl.mie.utoronto.ca ) at the University of Toronto (U of ... of zebrafish embryos. , Based on computer vision ... of immobilizing a large number of zebrafish embryos into ...
Other Medicine News:Health News:New report on mobile phone research published 2Health News:Photo: Tanger Outlet Center Shoppers Nationwide can Choose Pink to Fight Breast Cancer 2Health News:Atlanta Falcons Physical Therapy Centers Set to Launch This Fall 2Health News:Atlanta Falcons Physical Therapy Centers Set to Launch This Fall 3Health News:Health Integrated to Showcase Synergy Personal Health Management(R) at DMAA Conference 2
(Date:12/16/2009)... AMSTERDAM, December 16 Today, Avantium ... Executive Officer of its pharmaceutical,business. Gunnar Staaf ... and Eli Lilly & Company, in a ... is an important step in Avantium,s plan ... to create a,stand-alone pharmaceutical company based on ...
(Date:12/16/2009)... Senate Vote Against Lower Prescription Drug Prices ... Senate on Tuesday night rejected an amendment to ... would help make prescription drugs more affordable by ... lower priced drugs from abroad. The bipartisan ... Dorgan, Snowe, McCain, Grassley and Stabenow, would have ...
(Date:12/16/2009)... Calif., Dec. 16 Frost & ... Bujnoch, looks forward to speaking at the ... taking place on January 9, 2010 in ... the emerging market of consumer-based digital health ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, Bujnoch ...
Breaking Medicine Technology:Avantium Appoints Gunnar Staaf as CEO Pharma 2AARP Illinois Key Vote News Alert 2Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit 2Optimization and Scale up of a Hydrodynamically Limited Anti Solvent Crystallization Process 3A From Lab to Plant 13541 1Optimization and Scale up of a Hydrodynamically Limited Anti Solvent Crystallization Process 3A From Lab to Plant 13541 2TrueVision Teams with Ophthalmologists to Help Cure World Blindness for Treatable Cataracts Debut of 3D Training Video for Manual Small Incision C 54393 1TrueVision Teams with Ophthalmologists to Help Cure World Blindness for Treatable Cataracts Debut of 3D Training Video for Manual Small Incision C 54393 2TrueVision Teams with Ophthalmologists to Help Cure World Blindness for Treatable Cataracts Debut of 3D Training Video for Manual Small Incision C 54393 3TrueVision Teams with Ophthalmologists to Help Cure World Blindness for Treatable Cataracts Debut of 3D Training Video for Manual Small Incision C 54393 4Medco Health Solutions United Drug Announce U K Homecare Pharmacy Joint Venture Serving Patients with Chronic and Complex Health Conditions 3B Innov 54388 1Medco Health Solutions United Drug Announce U K Homecare Pharmacy Joint Venture Serving Patients with Chronic and Complex Health Conditions 3B Innov 54388 2Medco Health Solutions United Drug Announce U K Homecare Pharmacy Joint Venture Serving Patients with Chronic and Complex Health Conditions 3B Innov 54388 3
... Product Candidate in Clinical Trials, SEATTLE, Sept. ... enrolling patients in a Phase 1/Phase 2 study ... use during,ophthalmologic surgery. At least 60 patients undergoing ... enrollment in the,study., "With the initiation of ...
... 8 FluoroPharma, Inc. announced today that,Dr. ... Advisor,will report on two preclinical studies demonstrating ... molecular imaging agents for detection,of Alzheimer,s disease ... Molecular,Imaging Congress, in Nice, France on September ...
Other Medicine Technology:Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302 2FluoroPharma, Inc. to Report Preclinical Data on Alzheimer's Disease and Prostate Cancer PET Imaging Agents 2FluoroPharma, Inc. to Report Preclinical Data on Alzheimer's Disease and Prostate Cancer PET Imaging Agents 3
... The Volk G-1 trabeculum provides the highest magnification ... for viewing and treating the trabecular meshwork. ... the anterior chamber angle while the central portion ... the posterior pole for signs of glaucoma and ...
... Volks Disposable SSV® Vitrectomy Lenses are a ... to enable a view of a particular region ... contact lens element weighs less than 1 gram ... with the typical shape of a human cornea. ...
... 30° Prism are designed for ... recommended for tractional retinal detachments ... retinal detachment. They can be ... other midperipheral laser applications. Direct ...
... The 30° Prism is ... pathologies and are recommended ... (PDR, BRVO etc.) and ... can be used for ...
Medicine Products: